High TNF-alpha plasma levels and macrophages iNOS and TNF-alpha expression as risk factors for painful diabetic neuropathy

Journal of Pain Research

Volumn 4, Issue , 2011, Pages 169-175

  Purwata, Thomas Eko ^a  

^a UDAYANA UNIVERSITY   (Indonesia)

Author keywords

Diabetic neuropathic pain; iNOS; Tumor necrosis factor alpha

Indexed keywords

EID: 84862300506     PISSN: 11787090     EISSN: None     Source Type: Journal    
DOI: 10.2147/JPR.S21751     Document Type: Article

References (27)

1. Uceyler N, Sommer N. Status of immune mediators in painful neuropathies. Current Pain and Headache Report. 2008;12:159-164.
2. Davies M, William R, Brophy S, Taylor A. The prevalence, severity and impact of painful diabetic peripheral neuropathy in type 2 diabetes. Diabetes Care. 2006;29:1518-1522.
3. Moalem G, Tracey DJ. Immune and inflammatory mechanisms in neuropathic pain. Brain Res Rev. 2006;51:240-264.
4. Koch A, Zacharowski K, Boehm O, et al. Nitric oxide and pro-inflammatory cytokines correlate with pain intensity in chronic pain patients. Inflamm Res. 2007;56:32-37.
5. Sommer C, Schäfers M. Mechanisms of neuropathic pain: the role of cytokines. Drug Discov Today. 2004;1:441-446.
6. Moalem G, Tracey DJ. Immune and inflammatory mechanisms in neuropathic pain. Brain Res Rev. 2006;51:240-264.
7. Thacker MA, Clark AK, Marchand F, McMahon SB. Pathophysiology of peripheral neuropathic pain: immune cells and molecules. Anesth Analg. 2007;105:838-847.
8. Schäfers M, Svensson CI, Sommer C, Sorkin LS. Tumor necrosis factor-alpha induces mechanical allodynia after spinal nerve ligation by activation of p38 MAPK in primary sensory neurons. J Neurosci. 2003;23:2517-2521.
9. Dinarello CA. 1999. Overview of inflamatory cytokines and their role in pain. In: Watkins LR, Maier SF, editors. Cytokines and Pain. Basel: Birkhauser Verlag; 2003:1-39.
10. Jin X, Gerean R. Acute p38-mediated modulation of tetrodotoxinresistent sodium channels in mouse sensory neuron by tumor necrosis factor-α. J Neurosci. 2006;26:246-255.
11. Lowenstein CJ, Dinerman JL, Snyder SH. Nitric oxide: a physiologic messenger. Ann Intern Med. 1994;120:227-237.
12. Sharma S, Chopra K, Kulkarni SK. Effect of insulin and its combination with resveratrol or curcumin in attention of diabetic neuropathic pain: participation of nitric oxide and TNF-alpha. Phytother Res. 2007;21:278-283.
13. Quan D. Diabetic neuropathy. http://emedicine.medscape.com/ article/1170337-overview. Accessed Sep 20, 2008.
14. Emp M, Renaud S, Erne B, et al. TNF-alpha expression in painful and nonpainful neuropathies. Neurology. 2001;56:1371-1377.
15. Üçeyler N, Rogausch JP, Toyka KV, Sommer C. Differential expression of cytokines in painful and painless neuropathies. Neurology. 2007;69:42-49.
16. Dogonay S, Evereklioglu C, Turkoz Y, Servinc A, Mehmet N, Savli H. Comparison of serum NO, TNF-α, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus. Eye. 2002;16:163-170.
17. Üçeyler N, Kafke W, Riediger N, et al. Elevated proinflammatory cytokine expression in affected skin in small f iber neuropathy. Neurology. 2010;74:1806-1813
18. Chen DY, Lan JL, Lin FJ, Hsieh TY. Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still's disease. J Rheumatol. 2004;31:2189-2198.
19. Gur A, Karakoc K, Cevik R, Denli A, Sarac J. Cytokine and depression in cases with fibromyalgia. J Rheumatol. 2002;29:358-361.
20. De Caterina R, Libby P, Peng HB, et al. Nitric oxide decreases cytokine-induced endothelial activation: nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest. 1995;96:60-68.
21. Satoh J, Yagihashi S, Toyota T. The possible role of tumor necrosis factor-alpha in diabetic polyneuropathy. Exp Diabesity Res. 2003;4: 65-71.
22. Tegeder L, Niederberger E, Schmidt R, et al. Specific inhibition of IkappaB kinase reduces hyperalgesia in inflammatory and neuropathic pain models in rats. J Neurosci. 2004;24:1637-1645.
23. Mollace, V, Muscoli C, Rotiroti D, Nisticom G. Spontaneous induction of nitric oxide-and prostaglandin E2-release by hypoxic astroglial cells is modulated by interleukin 1 beta. Biochem Biophys Res Commun. 1997;238:916-919.
24. Togashi H, Sasaki M, Frohman E, et al. Neuronal (type I) nitric oxide synthase regulates nuclear factor kappaB activity and immunologic (type II) nitric oxide synthase expression. Proc Natl Acad Sci U S A. 1997;94:2676-2680.
25. Nathan C. NO as a secretory product of mammalian cells. FASEB J. 1992;6:3051-3064
26. De Alba JD, Clayton NM, Collins SD, Colthup P, Chessell IK. GW 274150, a novel and highly selective of the iNOS, shows analgesic effects in rat models of inflammatory and neuropathic pain. Pain. 2006;120:170-181.
27. Meller ST, Cummings CP, Traub RJ, Gebhart GF. The role of nitric oxide in the development and maintenance of the hyperalgesia produced by intraplantar injection of carrageenan in the rat. Neuroscience. 1994;60:367-374.